Clinical Trials Directory

Trials / Completed

CompletedNCT01606839

Noninvasive Measurement of Cardiac Output in Pulmonary Hypertension Using Inert Gas Rebreathing

Status
Completed
Phase
Study type
Observational
Enrollment
34 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study hypothesis is that accuracy of CO measurement by IGR does not differ from classical CO measurement methods such as thermodilution or direct Fick method. This is why the study aims to determine whether non invasive cardiac output (CO) measurement using inert gas rebreathing (IGR)is a suitable method in patients with pulmonary hypertension. In order to examine this, the IGR method will be used in patients undergoing diagnostic or follow-up right heart catheterization.

Detailed description

Inert Gas Rebreathing method enables non invasive measurement of cardiac output (CO) using the single rebreathing method. A mixture of blood soluble (N2O) and blood insoluble gas (SF6) and environmental air is inhaled and the amount of N2O, SF6, O2 and CO2 is measured by a photoacoustic analysator. The length of a measurement is about 1 minute. As the gold standard measurement of CO is performed invasively, there is an urgent need for the development of non-invasive tools like IGR.

Conditions

Timeline

Start date
2012-02-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2012-05-28
Last updated
2014-02-19

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01606839. Inclusion in this directory is not an endorsement.

Noninvasive Measurement of Cardiac Output in Pulmonary Hypertension Using Inert Gas Rebreathing (NCT01606839) · Clinical Trials Directory